Senior insider sale
SAREPTA THERAPEUTICS, INC. — senior position signals high conviction
$1.31M
10.50K shares
What this filing means
WIGZELL HANS LENNART RUDOLF plans to sell 10.50K shares of SAREPTA THERAPEUTICS, INC. valued at approximately $1.31M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/12/2024ACC: 0001972362-24-001860
Director
Since Nov 2018
10.50K
Shares to sell
$1.31M
Approx. market value
10.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
12/12/2024
10.50KTotal acquired10.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2024 | STOCK OPTION EXERCISE COMPENSATION | 10.50K | — |
| Total | 10.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10.50K
Market value
$1.31M
12/12/2024
Total
Units
10.50K
Value
$1.31M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/12/2024 | 10.50K | $1.31M | NASDAQ | Planned |
| Total | 10.50K | $1.31M | ||